RET p.Ser224Ter
c.668_669dup · VCV3644687
Pathogenic
Single submitter
Classification
Pathogenic
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
Consequence
nonsense (stop-gain)
predicted LoF
gnomAD v4.1
Rare
Conditions
1
multiple endocrine neoplasia type 2
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function in a haploinsufficient gene (ClinGen) |
|---|---|---|
| NMD | predicted | premature termination codon in exon 4 of 20 |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP 2.6 | GERP -0.22, phastCons 1 |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Variant & gene context
- Gene
- RET
- Protein
- p.Ser224Ter
- Coding
- c.668_669dup
- MANE Select
- NM_020975
- Type
- Duplication
- Location
- chr10:43104992 (GRCh38)
- Gene constraint
- LOEUF 0.24 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 79.27 · 34 PDB
- Residue 224
- a β-strand; a disulfide bond; the cadherin domain
Disease context
multiple endocrine neoplasia type 2 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Multiple endocrine neoplasia type 2 (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adolescent, Adult, Childhood, Infancy
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- RET p.Ser224Cys Uncertain significance ★ ⚠ same residue
- RET p.Ser224Thr Uncertain significance ★ ⚠ same residue
- RET p.Ser224= Likely benign ★ same residue
- RET p.Pro956fs Pathogenic ★★ same condition
- RET c.3027_3039+19dup Uncertain significance ★★ same condition
- RET p.Arg177_Glu178insIleArg Uncertain significance ★★ same condition
- RET p.Cys630_Asp631insProLeuCys Uncertain significance ★★ same condition
- RET p.Leu17_Leu18insArgLeuLeuLeuLeuLeu Uncertain significance ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ret-p-ser224ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown